Andrea Abate

7PUBLICATIONS
35CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 11, 2026
Updating ACC preclinical models: characterization of two new patient-derived cell lines.

|Mar 05, 2026
Prognostic role of pretreatment [18F]FDG PET/CT in patients affected by adrenocortical carcinoma and treated with chemotherapy.

Francesco Dondi, Davide Lorenzo Bettini, Deborah Cosentini

|Aug 20, 2024
A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma Cell Lines, PDX, and Patient Samples.

Yasuhiro Arakawa, Fathi Elloumi, Sudhir Varma

|Sep 28, 2023
Correction: Sigala et al. A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma. Cells 2022, 11, 1439.

Sandra Sigala, Christina Bothou, David Penton

|Nov 30, 2022
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models.

Andrea Abate, Mariangela Tamburello, Elisa Rossini

|Jul 25, 2022
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art?

Valentina Cremaschi, Andrea Abate, Deborah Cosentini

Pageof 2

Frequent Collaborators

4 joint publications

Alfredo Berruti

3 joint publications

Sandra Sigala

3 joint publications

Mariangela Tamburello

2 joint publications

Salvatore Grisanti